Pharmacovigilance Outsourcing Market (By Service: Pre-marketing services [Clinical pharmacovigilance services, Case processing services, Safety data management services, Medical review], Post-marketing services [Knowledge process outsourcing services, IT solutions and services], Others; By Service Provider: Contract research organizations (CROs), Business process outsourcing (BPOs)) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Pharmacovigilance Outsourcing
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Pharmacovigilance Outsourcing Market By Service
                1.2.2.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service (2015-2026)
                1.2.2.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service in 2017
                1.2.2.3. Pre-marketing services
                1.2.2.4. Post-marketing services
                1.2.2.5. Others
       1.2.3. Pharmacovigilance Outsourcing Market By Service Provider
                1.2.3.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service Provider (2015-2026)
                1.2.3.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service Provider in 2017
                1.2.3.3. Contract research organizations (CROs)
                1.2.3.4. Business process outsourcing (BPOs)
                1.2.3.5. Others
       1.2.4. Pharmacovigilance Outsourcing Market by Geography
                1.2.4.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                1.2.4.2. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
                1.2.4.3. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
                1.2.4.4. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
                1.2.4.5. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
                1.2.4.6. Middle East and Africa (MEA) Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017

CHAPTER 4. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE

4.1. Global Pharmacovigilance Outsourcing Revenue By Service
4.2. Pre-marketing services
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Post-marketing services
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE PROVIDER

5.1. Global Pharmacovigilance Outsourcing Revenue By Service Provider
5.2. Contract research organizations (CROs)
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Business process outsourcing (BPOs)
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

6.1. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
       6.3.1. U.S. Pharmacovigilance Outsourcing Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
6.4. Canada
       6.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
6.5. Mexico
       6.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

7.1. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
       7.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.4. Germany
       7.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.5. France
       7.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.6. Spain
       7.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       7.6.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.7. Rest of Europe
       7.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       7.7.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

8.1. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
       8.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.4. Japan
       8.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.5. India
       8.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.6. Australia
       8.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       8.6.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.7. South Korea
       8.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       8.7.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
       8.8.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       8.8.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

9.1. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
       9.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
9.4. Argentina
       9.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
9.5. Rest of Latin America
       9.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

10.1. Middle East Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
        10.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
        10.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
10.4. UAE
        10.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
        10.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
10.5. Rest of Middle East
        10.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
        10.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY

11.1. Africa Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
        11.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
        11.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
11.4. Egypt
        11.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
        11.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
11.5. Rest of Africa
        11.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
        11.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Bioclinica
        12.1.1. Company Snapshot
        12.1.2. Overview
        12.1.3. Financial Overview
        12.1.4. Product Portfolio
        12.1.5. Key Developments
        12.1.6. Strategies
12.2. Clintec
        12.2.1. Company Snapshot
        12.2.2. Overview
        12.2.3. Financial Overview
        12.2.4. Product Portfolio
        12.2.5. Key Developments
        12.2.6. Strategies
12.3. Covance
        12.3.1. Company Snapshot
        12.3.2. Overview
        12.3.3. Financial Overview
        12.3.4. Product Portfolio
        12.3.5. Key Developments
        12.3.6. Strategies
12.4. Medpace Holdings
        12.4.1. Company Snapshot
        12.4.2. Overview
        12.4.3. Financial Overview
        12.4.4. Product Portfolio
        12.4.5. Key Developments
        12.4.6. Strategies
12.5. Oracle Corporation
        12.5.1. Company Snapshot
        12.5.2. Overview
        12.5.3. Financial Overview
        12.5.4. Product Portfolio
        12.5.5. Key Developments
        12.5.6. Strategies
12.6. iGATE Corporation
        12.6.1. Company Snapshot
        12.6.2. Overview
        12.6.3. Financial Overview
        12.6.4. Product Portfolio
        12.6.5. Key Developments
        12.6.6. Strategies
12.7. Accenture
        12.7.1. Company Snapshot
        12.7.2. Overview
        12.7.3. Financial Overview
        12.7.4. Product Portfolio
        12.7.5. Key Developments
        12.7.6. Strategies
12.8. iMED Global Corporation
        12.8.1. Company Snapshot
        12.8.2. Overview
        12.8.3. Financial Overview
        12.8.4. Product Portfolio
        12.8.5. Key Developments
        12.8.6. Strategies
12.9. Symogen
        12.9.1. Company Snapshot
        12.9.2. Overview
        12.9.3. Financial Overview
        12.9.4. Product Portfolio
        12.9.5. Key Developments
        12.9.6. Strategies
12.10. Ergomed
          12.10.1. Company Snapshot
          12.10.2. Overview
          12.10.3. Financial Overview
          12.10.4. Product Portfolio
          12.10.5. Key Developments
          12.10.6. Strategies
12.11. IBM Corporation
          12.11.1. Company Snapshot
          12.11.2. Overview
          12.11.3. Financial Overview
          12.11.4. Product Portfolio
          12.11.5. Key Developments
          12.11.6. Strategies
12.12. IQVIA
          12.12.1. Company Snapshot
          12.12.2. Overview
          12.12.3. Financial Overview
          12.12.4. Product Portfolio
          12.12.5. Key Developments
          12.12.6. Strategies
12.13. MarksMan Healthcare
          12.13.1. Company Snapshot
          12.13.2. Overview
          12.13.3. Financial Overview
          12.13.4. Product Portfolio
          12.13.5. Key Developments
          12.13.6. Strategies
12.14. Parexel
          12.14.1. Company Snapshot
          12.14.2. Overview
          12.14.3. Financial Overview
          12.14.4. Product Portfolio
          12.14.5. Key Developments
          12.14.6. Strategies
12.15. SIRO Clinpharm
          12.15.1. Company Snapshot
          12.15.2. Overview
          12.15.3. Financial Overview
          12.15.4. Product Portfolio
          12.15.5. Key Developments
          12.15.6. Strategies
12.16. Novartis
          12.16.1. Company Snapshot
          12.16.2. Overview
          12.16.3. Financial Overview
          12.16.4. Product Portfolio
          12.16.5. Key Developments
          12.16.6. Strategies
12.17. Others
          12.17.1. Company Snapshot
          12.17.2. Overview
          12.17.3. Financial Overview
          12.17.4. Product Portfolio
          12.17.5. Key Developments
          12.17.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
        13.1.1. Initial Data Search
        13.1.2. Secondary Research
        13.1.3. Primary Research
13.2. Assumptions and Scope